Results 201 to 210 of about 109,064 (360)

A survey of ocular pathology in Warmblood horses in South Africa

open access: yesEquine Veterinary Journal, Volume 57, Issue 4, Page 889-897, July 2025.
Abstract Background Warmblood horses are a popular breed around the world for equestrian sports. Previous studies have investigated ocular findings in other breeds of horses; however, no studies exist for the Warmblood breed. Objectives To determine the prevalence of ocular abnormalities in a convenience sample of Warmblood horses in South Africa and ...
Ramona Allen, Antony D. Goodhead
wiley   +1 more source

Elucidating the Molecular Landscape of Cystic Kidney Disease: Old Friends, New Friends and Some Surprises

open access: yesAmerican Journal of Medical Genetics Part A, Volume 197, Issue 6, June 2025.
ABSTRACT Cystic kidney diseases (CyKD) are a diverse group of disorders affecting more than 1 in 1000 individuals. Over 120 genes are implicated, primarily encoding components of the primary cilium, transcription factors, and morphogens. Prognosis varies greatly by molecular diagnosis. Causal variants are not identified in 10%–60% of individuals due to
Deborah Watson   +10 more
wiley   +1 more source

Roadmap to Nanomedical Applications: Nanotoxicology and In Vitro Guidelines for Lanthanide‐Doped Luminescence Nanothermometers

open access: yesAdvanced NanoBiomed Research, Volume 5, Issue 6, June 2025.
Lanthanide‐based luminescence nanothermometry holds multifaceted potential for nanomedical applications, yet despite significant research advances, clinical translation of the engineered nanomaterials is still controversial and widely disputed. This is related to crucial nanotoxicological aspects that must be addressed at the preclinical level ...
Simona Premcheska   +2 more
wiley   +1 more source

Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

open access: bronze, 1982
David G. Payne   +3 more
openalex   +1 more source

Exploring of Antidepressant Components and Mechanisms of Zhizichi Decoction: Integration of Serum Pharmacochemistry, Network Pharmacology and Anti‐inflammatory Analysis Verification

open access: yesAnalytical Science Advances, Volume 6, Issue 1, June 2025.
ABSTRACT Using LC–MS to screen and analyse the characteristics of components and biological systems is a new approach to study the pharmacological substance basis of traditional Chinese medicine, which has strong novelty in analytical science. This study analyses the antidepressant material basis of Zhizichi decoction through the integration strategy ...
Chuan Chai   +7 more
wiley   +1 more source

Three-dimensional cultured glioma cell lines [PDF]

open access: yes
Three-dimensional glioma spheroids were produced in vitro with size and histological differentiation previously unattained. The spheroids were grown in liquid media suspension in a Johnson Space Center (JSC) Rotating Wall Bioreactor without using support
Gonda, Steve R., Marley, Garry M.
core   +1 more source

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

open access: yesThe Lancet Oncology, 2012
W. Wick   +17 more
semanticscholar   +1 more source

Induction of metallothionein in a human astrocytoma cell line by interleukin‐1 and heavy metals [PDF]

open access: bronze, 1993
Yutaka Kikuchi   +4 more
openalex   +1 more source

5‐ALA Assisted Surgery of Human Glioblastoma Samples Reveals an Enrichment of T Cells Expressing PD‐1 and CD103 in the Intermediate and Marginal Layers

open access: yesEuropean Journal of Immunology, Volume 55, Issue 6, June 2025.
Flow‐cytometric analysis of glioblastoma immune infiltrates showed a significantly higher frequency of T lymphocytes expressing PD‐1, CD69, and CD103. In particular, we observed a preferential enrichment of CD8+ T cells expressing PD‐1 and Trm markers in intermediate and marginal tumor areas, in which glioblastoma cells showed an active 5‐ALA ...
Anna Vanni   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy